Novo Nordisk partners with OpenAI as AI drug discovery hopes mount

CNBC — Apr 14, 06:20 AM

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

Read full article at CNBC →

Novo Nordisk partners with OpenAI

Novo Nordisk teams up with OpenAI to boost AI-driven drug discovery efforts Seeking Alpha — Apr 14, 06:37 AM
Novo Nordisk and OpenAI Partner to Speed Drug Discovery Wall Street Journal — Apr 14, 06:37 AM
Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - Reuters Reuters — Apr 14, 06:04 AM
Novo Taps OpenAI to Speed Development of New Obesity Drugs Bloomberg — Apr 14, 06:00 AM